Joint Clinical Assessments extend to selected high-risk medical devices and in-vitro diagnostics
European Commission · September 07, 2025
HTA Regulation: Joint Clinical Assessments extended to selected high-risk medical devices and in-vitro diagnostics
Original title: HTA Regulation - Medical Devices
Joint Clinical Assessments under the HTA Regulation now extend to selected high-risk medical devices and in-vitro diagnostics, expanding scope beyond pharmaceuticals.
Enters Force
January 01, 2026
Published by European Commission. HealthSignal links to the original document; the summary above is extracted from the source text.